Key result
Continuous thoracic epidural analgesia decreased narcotic requirements in the PACU and the first 24 hours after surgery compared to intravenous pain control.
Why the study?
Does continuous thoracic epidural analgesia reduce opioid use and pain scores compared to intravenous analgesia in patients undergoing laparoscopic abdominal surgery?
Observational
No
Does continuous thoracic epidural analgesia reduce opioid use and pain scores compared to intravenous analgesia in patients undergoing laparoscopic abdominal surgery?
Continuous thoracic epidural analgesia provides superior pain control and reduces opioid requirements compared to intravenous analgesia following laparoscopic abdominal surgery.
Answers are grounded in this paper and cite their sources.
May support opioid-sparing epidural use in laparoscopic surgery; hypothesis-generating and requires randomized confirmation before practice change.
Introduction/Background: This study evaluates the effects of continuous thoracic epidural analgesia (TEA) vs. intravenous pain control methods on the narcotics requirement for common laparoscopic abdominal surgeries. The introduction of new guidelines at Tampa General Hospital for the year 2017 afforded the opportunity for a sequential case series analysis of these two methods of pain management. Methods: A sequential case-series on patients undergoing laparoscopic or robot assisted abdominal surgery was performed. Patients were recruited upon request of surgeons using the same nurses and resident support team. Data were obtained from retrospective chart review following local IRB approval and evaluated for the effects of intravenous analgesia compared to continuous T9-10 epidural analgesia. Primary outcomes were intraoperative, 24 h and post-24 h opioid use in morphine milligram equivalents (MME). Length of hospital stay and VAS pain scores were also collected. Results: There was no significant difference in terms of age, gender, and BMI between groups. When compared patients who received epidural reported significantly lower pain scores in the first 24 h after surgery (p<0.05) and for the remainder of their hospital stay (p<0.05). Significant decreases in narcotic requirement was noted in the PACU (p<0.001), the first 24 h after surgery (p<0.001), and aggregate use per day (p<0.01). Conclusions: Continuous thoracic epidural analgesia is a viable alternative to intravenous pain control for patients undergoing common laparoscopic surgeries. Further research is required to determine the risks and benefits of TEA for laparoscopic colorectal surgery.
No takes yet. Share an insight, caveat, or question.
Enten et al. (2018) conducted an observational in Laparoscopic or robot assisted abdominal surgery. Continuous thoracic epidural analgesia (TEA) vs. Intravenous pain control methods was evaluated on Intraoperative, 24 h and post-24 h opioid use in morphine milligram equivalents (MME) (p=<0.001). Continuous thoracic epidural analgesia decreased narcotic requirements in the PACU and the first 24 hours after surgery compared to intravenous pain control.
Synapse has enriched 10 related papers. Consider them for comparative context: